Latest kidney cancer news
NHS England to trial new blood test for over 50 types of cancer
NHS England is about to start a large-scale trial of [...]
Patient leaders join new pharmaceutical industry Patient Advisory Council
The Association of the British Pharmaceutical Industry (ABPI) have formed [...]
Stereotactic radiotherapy for patients on TKIs
Stereotactic radiotherapy is a very precise method of radiotherapy that [...]
Cabozantinib in pretreated patients with sarcomatoid kidney cancer
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive form of [...]
Camrelizumab plus famitinib in patients with advanced or metastatic kidney cancer
An ongoing phase 2 study of a combination of two [...]
3D modelling of kidney tumours
Surgeons use three-dimensional (3D) models to improve their understanding of [...]
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo kidney cancer sunitinib cabozantinib Sutent progression-free survival NHS England biomarkers ipilimumab pembrolizumab Cabometyx axitinib COVID-19 cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus risk factors Yervoy adjuvant therapy Keytruda targeted therapy metastases papillary RCC everolimus biological markers ASCO Afinitor cancer outcomes first-line treatment NICEArchives
- 2025: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
